Physician profile
John Mcglynn
NPI 1508327529
$455.56
in general payments reported to CMS, 2019-2025
11 companies · $266 in 2025
The $266 reported for 2025 was more than what a typical Undersea and Hyperbaric Medicine (Emergency Medicine) provider received nationally (typical 2025 total: $153).
See the full distribution for Undersea and Hyperbaric Medicine (Emergency Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $62.64 · 2024: $127 · 2025: $266.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $455.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $97.43 | 2025 | Cobenfy |
| Solventum Corporation | $82.18 | 2024-2025 | V.A.C. Veraflo Cleanse Choice, V.A.C.Ulta, Activ.A.C. |
| Smith+Nephew, INC. | $75.92 | 2024-2025 | Duramax S Silicone Super Absorbent Dressing, Allevyn Life L 15.4x15.4 Ctn10, Pico 7 |
| Organogenesis INC. | $52.62 | 2025 | Puraply Wound Matrix |
| Kci USA, INC. | $35.40 | 2023 | Activ.A.C., V.A.C. Dermatac, V.A.C. Veraflo Cleanse Choice |
| Medtronic, INC. | $27.24 | 2023 | Venaseal |
| Orthofix Medical, INC. | $24.54 | 2025 | Truelok |
| Kerecis Limited | $18.60 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Tactile Systems Technology INC | $14.80 | 2025 | Nimbl, Flexitouch Plus |
| Medline Industries LP | $13.63 | 2025 | |
| Molnlycke Health Care US, LLC | $13.20 | 2025 | Exufiber, Mepilex Transfer Ag, Tubigrip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcglynn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.